These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 18008365)
1. Prognostic significance of mesenteric tumor nodules in patients with stage III colorectal cancer. Lo DS; Pollett A; Siu LL; Gallinger S; Burkes RL Cancer; 2008 Jan; 112(1):50-4. PubMed ID: 18008365 [TBL] [Abstract][Full Text] [Related]
2. The clinicopathological significance of inferior mesenteric lymph node metastasis in colorectal cancer. Kim JC; Lee KH; Yu CS; Kim HC; Kim JR; Chang HM; Kim JH; Kim JS; Kim TW Eur J Surg Oncol; 2004 Apr; 30(3):271-9. PubMed ID: 15028308 [TBL] [Abstract][Full Text] [Related]
3. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Sarli L; Bader G; Iusco D; Salvemini C; Mauro DD; Mazzeo A; Regina G; Roncoroni L Eur J Cancer; 2005 Jan; 41(2):272-9. PubMed ID: 15661553 [TBL] [Abstract][Full Text] [Related]
4. An audit of outcomes in colorectal cancer in China. Zong XY; Shi YQ Eur J Surg Oncol; 2007 Mar; 33(2):169-73. PubMed ID: 17097261 [TBL] [Abstract][Full Text] [Related]
5. The mesenteric and antimesenteric site of the tumor as possible prognostic factor in colorectal cancer: 5-year survival analysis. Boni L; Cantore F; Colombo E; Benevento A; Dionigi G; Rovera F; Capriata G; Dettori G; Dionigi R Surg Oncol; 2007 Dec; 16 Suppl 1():S79-82. PubMed ID: 18032025 [TBL] [Abstract][Full Text] [Related]
6. The number of analyzed lymph nodes - a prognostic factor in colorectal cancer. Edler D; Ohrling K; Hallström M; Karlberg M; Ragnhammar P Acta Oncol; 2007; 46(7):975-81. PubMed ID: 17917828 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy. Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948 [TBL] [Abstract][Full Text] [Related]
8. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261 [TBL] [Abstract][Full Text] [Related]
9. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases. Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284 [TBL] [Abstract][Full Text] [Related]
10. Defining stage III disease in colorectal cancer--aspects on treatment and evaluation of survival. Derwinger K; Carlsson G; Ekman T J Surg Oncol; 2010 Oct; 102(5):424-7. PubMed ID: 20607755 [TBL] [Abstract][Full Text] [Related]
11. Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups. Zlobec I; Baker K; Minoo P; Hayashi S; Terracciano L; Lugli A Cancer; 2009 Sep; 115(17):4021-9. PubMed ID: 19517467 [TBL] [Abstract][Full Text] [Related]
12. Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock Cancer Registry. Fietkau R; Zettl H; Klöcking S; Kundt G Strahlenther Onkol; 2004 Aug; 180(8):478-87. PubMed ID: 15292968 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis. Rossi PJ; Jani AB; Horowitz IR; Johnstone PA Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):134-8. PubMed ID: 17855014 [TBL] [Abstract][Full Text] [Related]
14. Circular tumor growth: a prognostic factor in stage II colorectal carcinoma. Jimi S; Hotokezaka M; Eto TA; Hidaka H; Maehara N; Chijiiwa K Hepatogastroenterology; 2008; 55(84):926-9. PubMed ID: 18705299 [TBL] [Abstract][Full Text] [Related]
15. Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion. Strzelczyk B; Szulc A; Rzepko R; Kitowska A; Skokowski J; Szutowicz A; Pawelczyk T Ann Surg Oncol; 2009 May; 16(5):1287-94. PubMed ID: 19259744 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108 [TBL] [Abstract][Full Text] [Related]
17. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved. Tsikitis VL; Larson DL; Wolff BG; Kennedy G; Diehl N; Qin R; Dozois EJ; Cima RR J Am Coll Surg; 2009 Jan; 208(1):42-7. PubMed ID: 19228501 [TBL] [Abstract][Full Text] [Related]
18. Lymph node ratio: role in the staging of node-positive colon cancer. Wang J; Hassett JM; Dayton MT; Kulaylat MN Ann Surg Oncol; 2008 Jun; 15(6):1600-8. PubMed ID: 18327530 [TBL] [Abstract][Full Text] [Related]
19. Population-based registration of unselected colorectal cancer patients: five-year survival in the region of Bonn/Rhine-Sieg, Germany. Lamberti C; Di Blasi K; Archut D; Fimmers R; Mathiak M; Bollmann M; Vogel J; Kindermann D; Mezger J; Schmidt-Wolf IG; Sauerbruch T Z Gastroenterol; 2005 Feb; 43(2):149-54. PubMed ID: 15700204 [TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and disease outcome of UICC stages I-III colorectal cancer patients at Siriraj Hospital. Techawathanawanna S; Nimmannit A; Akewanlop C J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S189-98. PubMed ID: 22574549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]